Understanding prognostic gene expression signatures in lung cancer.
about
Predicting Prognosis of Early-Stage Non-Small Cell Lung Cancer Using the GeneFx® Lung SignatureIntegrative computational biology for cancer researchComprehensive evaluation of published gene expression prognostic signatures for biomarker-based lung cancer clinical studies.Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer.Using logistic regression to improve the prognostic value of microarray gene expression data sets: application to early-stage squamous cell carcinoma of the lung and triple negative breast carcinomaPrognostic factors in resected lung carcinomas.Smoking status impacts microRNA mediated prognosis and lung adenocarcinoma biologyTumor-microenvironment interactions studied by zonal transcriptional profiling of squamous cell lung carcinoma.Prognostic markers in lung cancer: is it ready for prime time?5-alpha-reductase type I (SRD5A1) is up-regulated in non-small cell lung cancer but does not impact proliferation, cell cycle distribution or apoptosis.A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studiesA potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.Lung cancer staging: a physiological update.KIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancer.Profiling of linker histone variants in ovarian cancer.Circulating plant miRNAs can regulate human gene expression in vitroConsensus of gene expression phenotypes and prognostic risk predictors in primary lung adenocarcinoma.Novel biomarkers of metastatic cancer.An omics strategy for discovering pulmonary biomarkers potentially relevant to the evaluation of tobacco products.New biomarkers for lung cancer.Prognostic and predictive biomarkers in early stage non-small cell lung cancer: tumor based approaches including gene signaturesRecurrence after surgery in patients with NSCLC.Towards mechanism classifiers: expression-anchored Gene Ontology signature predicts clinical outcome in lung adenocarcinoma patients.Lung Cancer Staging and Prognosis.Differentially expressed protein-coding genes and long noncoding RNA in early-stage lung cancer.Systematic Identification of Oncogenic EGFR Interaction Partners[Establishment of Orthotopic Xuanwei lung cancer SCID mouse model and analysis of biological properties].[Long-term survival of personalized surgical treatment of locally advanced non-small cell lung cancer based on molecular staging].
P2860
Q28608174-7328C51D-EEAE-4422-9CB9-AE7D4DDBECABQ28744621-8BE2ED1B-8BBF-438D-ACF5-4B5A68F0B77DQ30235944-C5E76B07-65CB-44A8-A804-F298D2D4DFD3Q30497419-2C9ABA34-99DE-4238-B65D-CFF85286E1D9Q30830295-4CAC227A-B69F-4757-93B0-6757FCD895F1Q33697964-78EF4761-E755-4A23-ABD9-4A94D1A939ADQ34436424-64E975F1-5E4E-496B-B18F-A7BD09E3EDE1Q34449094-72140D3B-43A0-4F93-AB27-46CEFB7A776EQ35200555-A6909409-C27E-4002-B67E-706F6F04ECCFQ35721207-C26E7AF2-953B-4FA8-BB1D-6F68ABE3AB26Q35803022-4789A7EA-6A72-42C6-9412-B26B17175A0BQ35857169-88CCD565-365D-4BD0-9DE7-DCC2E6F9115FQ35961771-7E6075A6-A094-423C-980F-069A2CDEEC2FQ36819651-AF97C2DD-AC6C-4057-A353-5F028C1D462EQ37125546-526E5396-7CAB-4F79-8644-B7EA6404236CQ37239945-F5029C10-AE30-4027-87BC-EE7BB65AA0FFQ37619692-066A82FC-CE18-4397-B6C9-CD78F09882CBQ37772496-4502D9F4-1D01-4EF5-865C-0821F5531F8EQ38066244-89E26678-3EBB-4C0A-B40E-C8B1DB623075Q38089079-D827C436-16FC-4702-BE4A-C13D8B367EDDQ38390072-BF49EDE0-1CBB-4E2D-83FD-B1E85CAB2796Q38390164-3B03069D-CF93-4624-B932-74C4AD8187A2Q38492817-9749B7A1-FEAD-440E-8988-0263E714B0CBQ38830349-F98F6036-67C8-4F8C-8ABD-E09D765E5F88Q38852610-1485DC2F-4C4D-41AF-B449-1A2BF902410AQ42149620-E6CC160A-D136-4F90-BFC7-75BCB5F66638Q55464322-A9BECBED-A37A-4BF4-92C1-F61149F4C0B6Q55464639-FC10A6AF-298D-49DB-97E6-FF9EEC8EACAD
P2860
Understanding prognostic gene expression signatures in lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Understanding prognostic gene expression signatures in lung cancer.
@en
Understanding prognostic gene expression signatures in lung cancer.
@nl
type
label
Understanding prognostic gene expression signatures in lung cancer.
@en
Understanding prognostic gene expression signatures in lung cancer.
@nl
prefLabel
Understanding prognostic gene expression signatures in lung cancer.
@en
Understanding prognostic gene expression signatures in lung cancer.
@nl
P2093
P356
P1433
P1476
Understanding prognostic gene expression signatures in lung cancer
@en
P2093
Chang-Qi Zhu
Dan Strumpf
Frances A Shepherd
Igor Jurisica
Melania Pintilie
Sandy D Der
P304
P356
10.3816/CLC.2009.N.045
P407
P577
2009-09-01T00:00:00Z